IPO Update: Hesai Group Pursues $162 Million U.S. IPO

IPO Update: Hesai Group Pursues $162 Million U.S. IPO By Donovan Jones Societe Generale: Poised For A Record Year By Cavenagh Research EDAP: Potential Crossover Of HIFU To Endometriosis Additional Inflection Points By Zach Bristow FEATURED: Get 50% off your first year of Premium! Earnings season can spark serious volatility. Now's the time to protect your portfolio and find compelling opportunities. Seeking Alpha Premium gives you in-depth, timely insights into almost every stock. Now 50% off your first year! Go Premium now » Long Ideas BNP Paribas' Earnings Report Could Surprise Many By Pearl Gray Equity and Research Why Piedmont Lithium Is Our Number 1 Stock Pick In 2023 By Trend Investing Albemarle: Growth Slowdown Looming By JR Research Chevron: End-Of-Cycle Oil Price Bet By On the Pulse Blue Owl Capital: Why Every Investor Needs To Check It Out By Alexander Steinberg More Long Ideas » Quick Picks & Lists Dump Meta Platforms While You Can (Rating Downgrade) By Paul Franke Robinhood Has Substantial Downside And That's Likely The Only Realistic Scenario By Trade Theory Alector: Trading At Cash Despite Late Stage CNS Pipeline By Avisol Capital Partners The Timken Company: Flexing Its Muscles By The Value Investor Builders FirstSource: Don't Be Mesmerized By The Past Few Years' Performance By Hong Chew Eu More Quick Picks & Lists » IPO Analysis IPO Update: CytoMed Therapeutics Aims For $11 Million U.S. IPO By Donovan Jones More IPO Analysis » Download the Seeking Alpha App! Like Stock Ideas? Try our other newsletters as well. This email was sent to you because you signed up to receive Stock Ideas. If you do not want to receive Stock Ideas emails, click here to unsubscribe. Sent by Seeking Alpha, 234 5th Ave, 5th floor, New York, NY 10001